Fig. 5From: Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variantRT-PCR analysis of FGF23 transcripts. All 3 FGF23 transcripts (23a, 140Â bp; 23b, 125Â bp; 23c, 175Â bp) were amplified in PMTs (with TIO: case Nos. 1, 2, without TIO: case Nos. 6, 7), whereas only 2 or 1 of the 3 transcripts were detected in the chondromyxoid fibroma sample (case No. 9) or the myxoid liposarcoma sample (case No. 23), respectively. M, 100-bp DNA ladder; N, negative control; PGK, phosphoglycerokinase; PBGD, porphobilinogen deaminase; CMF, chondromyxoid fibromaBack to article page